Atlas Trials

Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Clinical trial NCT00501826 · RECRUITING

Trial details

NCT number
NCT00501826
Sponsor
M.D. Anderson Cancer Center
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
T Acute Lymphoblastic LeukemiaT Lymphoblastic Lymphoma
Start date
2007-07-11
Primary completion
2026-10-31
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.